You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III grade 1 follicular lymphoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lower Urinary Tract Symptoms, Prostatic Hyperplasia, Prostatic Cancer Trial in Madrid (Temporary prostatic stent (Exime®),

Not yet recruiting
  • Lower Urinary Tract Symptoms
  • +3 more
  • Temporary prostatic stent (Exime®)
  • Indwelling catheter
  • Madrid, Spain
    Juan Ignacio Martinez-Salamanca
May 1, 2023

Non-Hodgkin Lymphoma Trial in Boston (Blinatumomab)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Boston, Massachusetts
    Massachusetts general Hospital
Jan 31, 2021

Hidradenitis Suppurativa Trial (PTM-001, Placebo)

Not yet recruiting
  • Hidradenitis Suppurativa
  • (no location specified)
May 12, 2022

Esophageal Squamous Cell Carcinoma Trial in Hangzhou (Cadonilimab combined Anlotinib)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Cadonilimab combined Anlotinib
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 6, 2023

Acute on Chronic Hepatic Failure, Liver Failure, Hepatitis Trial (HepaCure)

Not yet recruiting
  • Acute on Chronic Hepatic Failure
  • +2 more
  • HepaCure
  • (no location specified)
Aug 4, 2023

Neurofibromatosis 1, Plexiform Neurofibroma, NF1 Trial (Test group (Group A): FCN-159 8 mg, orally, once daily;, Control group

Not yet recruiting
  • Neurofibromatosis 1
  • +2 more
  • Test group (Group A): FCN-159 8 mg, orally, once daily;
  • Control group (Group B): Placebo, orally, once daily;
  • (no location specified)
Jun 16, 2023

Advanced Solid Tumor Trial in Brussels (GTAEXS617)

Recruiting
  • Advanced Solid Tumor
  • Brussels, Belgium
    Clinique Universitaires Saint-Luc
Aug 8, 2023

Obesity, Type 2 Diabetes, Sodium-glucose Co-transporter-2 Inhibitor Trial (Henagliflozin, Metformin)

Not yet recruiting
  • Obesity
  • +4 more
  • (no location specified)
Sep 27, 2023

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Topotecan)

    Not yet recruiting
    • Small Cell Lung Carcinoma (SCLC)
    • (no location specified)
    Aug 7, 2023

    Parkinson Disease Trial in San Jose, New York (Occupational therapy intervention group, Disease management education group)

    Recruiting
    • Parkinson Disease
    • Occupational therapy intervention group
    • Disease management education group
    • San Jose, California
    • +1 more
    Apr 25, 2022

    Lung Tumor Malignant Trial in Shanghai (sintilimab, bevacizumab)

    Not yet recruiting
    • Lung Neoplasm Malignant
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Jul 13, 2021

    Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Stony Brook, Nashville (TG-0054 combined with G-CSF)

    Completed
    Has Results
    • Multiple Myeloma
    • +2 more
    • TG-0054 combined with G-CSF
    • Stony Brook, New York
    • +1 more
    Apr 14, 2021

    Placenta Accreta Trial in Assiut (Pregnant women at 28-32 weeks, at delivery)

    Completed
    • Placenta Accreta
    • Pregnant women at 28-32 weeks
    • at delivery
    • Assiut, Egypt
      Woman's Health Hospital
    Aug 19, 2022

    Epithelial Ovarian Cancer Trial in Leiden ([18F]fluoro-PEG-folate PET/CT scan)

    Recruiting
    • Epithelial Ovarian Cancer
    • [18F]fluoro-PEG-folate PET/CT scan
    • Leiden, Zuid-holland, Netherlands
      Leiden University Medical Center
    Aug 17, 2022

    Nephrolithiasis Trial in New York (Fexofenadine Hcl 180Mg Tab, Placebo)

    Recruiting
    • Nephrolithiasis
    • Fexofenadine Hcl 180Mg Tab
    • Placebo
    • New York, New York
      Columbia University Irving Medical Center/NYP
    Jul 16, 2021

    Chronic Kidney Diseases, Osteodystrophy, Uric Acid Concentration, Serum, Quantitative Trait Locus 7 Trial in São Paulo

    Recruiting
    • Chronic Kidney Diseases
    • +2 more
    • São Paulo, SP, Brazil
      Hospital das Clinicas HCFMUSP
    Oct 26, 2022

    Depression, Parkinson Disease Trial (Nortriptyline, Escitalopram, Placebo)

    Recruiting
    • Depression
    • Parkinson Disease
    • London, United Kingdom
      Royal Free London NHS Foundation Trust
    Nov 2, 2022

    Typhoid Trial in Philippines (Vi-DT (Multi-dose formulation), Vi-DT (Single dose formulation), Control Vaccine)

    Completed
    • Typhoid
    • Vi-DT (Multi-dose formulation)
    • +2 more
    • Calamba, Laguna, Philippines
    • +3 more
    Aug 26, 2021

    Clear Cell Tumor, Gynecologic Cancer, Advanced Cancer Trial in United Kingdom (Pembrolizumab)

    Active, not recruiting
    • Clear Cell Tumor
    • +2 more
    • Edinburgh, United Kingdom
    • +4 more
    Oct 22, 2021

    Chromogranin A as Blood Marker in Cancer Patients

    Completed
    • Gastric Neoplasms
    • +3 more
    • BRAHMS CgA II KRYPTOR
    • Palo Alto, California
    • +3 more
    Dec 19, 2022

    Cervical Cancer Trial in Worldwide (AGEN1884 + AGEN2034)

    Completed
    • Cervical Cancer
    • AGEN1884 + AGEN2034
    • Goodyear, Arizona
    • +46 more
    Nov 2, 2022

    Kidney Transplant, Microcirculation Trial in Taipei (Dexmedetomidine)

    Recruiting
    • Kidney Transplant
    • Microcirculation
    • Taipei, Taiwan
      National Taiwan University Hospital
    Aug 15, 2022

    Prevention Trial in Stockholm (Modified Mindfetalness)

    Recruiting
    • Prevention
    • Modified Mindfetalness
    • Stockholm, Sweden
      Ingela Rådestad
    Sep 12, 2022

    Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

    Not yet recruiting
    • Diffuse Astrocytoma, IDH-Mutant
    • +20 more
    • NEO212 Oral Capsule
    • +8 more
    • (no location specified)
    Sep 18, 2023